Less Ads, More Data, More Tools Register for FREE

UK BROKER RATINGS SUMMARY: JPMorgan Upgrades Severn Trent To Neutral

Tue, 18th Feb 2020 09:29

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:



FTSE 100



JPMORGAN RAISES SEVERN TRENT TO 'NEUTRAL' ('UNDERWEIGHT') - PRICE TARGET 2550 (2000) PENCE



KEPLER CHEUVREUX CUTS ASTRAZENECA PRICE TARGET TO 7700 (8000) PENCE - 'BUY'



CITIGROUP CUTS BT GROUP PRICE TARGET TO 165 (205) PENCE - 'NEUTRAL'



CITIGROUP CUTS COCA-COLA HBC TO 'NEUTRAL' ('BUY')



MORGAN STANLEY CUTS ROYAL BANK OF SCOTLAND PRICE TARGET TO 275 (300) PENCE - 'OVERWEIGHT'



LIBERUM CUTS GLAXOSMITHKLINE PRICE TARGET TO 1840 (1930) PENCE - 'HOLD'



JPMORGAN RAISES UNITED UTILITIES PRICE TARGET TO 1100 (900) PENCE - 'OVERWEIGHT'



JPMORGAN RAISES COCA-COLA HBC PRICE TARGET TO 3100 (2900) PENCE - 'OVERWEIGHT'



FTSE 250



UBS CUTS HASTINGS GROUP PRICE TARGET TO 182 (190) PENCE - 'NEUTRAL'



BARCLAYS CUTS CONVATEC PRICE TARGET TO 182 (185) PENCE - 'EQUAL WEIGHT'



LIBERUM RAISES NETWORK INTERNATIONAL PRICE TARGET TO 680 (645) PENCE - 'BUY'



JPMORGAN CUTS WEIR GROUP PRICE TARGET TO 1300 (1380) PENCE - 'NEUTRAL'



JPMORGAN RAISES PENNON GROUP PRICE TARGET TO 1125 (760) PENCE - 'NEUTRAL'



OTHER MAIN MARKET AND AIM



BERENBERG RAISES PETRA DIAMONDS PRICE TARGET TO 11 (10) PENCE - 'HOLD'



JEFFERIES RAISES DRAPER ESPRIT PRICE TARGET TO 727 (672) PENCE - 'BUY'



Copyright 2020 Alliance News Limited. All Rights Reserved.

Related Shares

More News

TOP NEWS: Glaxo, Vir Biotechnology Collaborate For Covid-19 Treatment

TOP NEWS: Glaxo, Vir Biotechnology Collaborate For Covid-19 Treatment

6 Apr 20 13:39

GSK joins up with Vir Biotech on coronavirus treatments

(Sharecast News) - GlaxoSmithKline and Vir Biotechnology of the US have joined forces to research treatments for the virus behind the Covid-19 crisis and other coronaviruses.

6 Apr 20 13:19

JP Morgan boss anticipates financial stress akin to 2008 crisis

(Sharecast News) - The head of America's largest lender by market value is digging in for a severe downturn.

6 Apr 20 13:14

Monday broker round-up

(Sharecast News) - Anglo American: RBC Capital Markets downgrades to sector perform with a target price of 1,500p.

6 Apr 20 12:43

Login to your account

Don't have an account? Click here to register.